Abstract
Although the function of the kainate receptors in the brain is still not clear, they are increasingly defined as targets in the development of new classes of anti-epileptics. The thienopyrimidines described in this report were tested for their antagonistic effect at the kainate receptor subtypes GluR5 and GluR6. The highest effectiveness was obtained by a 4-ethoxy-thieno[2,3-d]pyrimidin with an IC50 = 68 microM at the GluR6 receptor.
MeSH terms
-
Brain Chemistry / drug effects
-
Cells, Cultured
-
Excitatory Amino Acid Antagonists / chemical synthesis
-
Excitatory Amino Acid Antagonists / pharmacology*
-
GluK2 Kainate Receptor
-
Humans
-
Indicators and Reagents
-
Magnetic Resonance Spectroscopy
-
Pyrimidines / pharmacology*
-
Receptors, Glutamate / drug effects*
-
Receptors, Kainic Acid / antagonists & inhibitors
-
Receptors, Kainic Acid / metabolism
Substances
-
Excitatory Amino Acid Antagonists
-
Gluk1 kainate receptor
-
Indicators and Reagents
-
Pyrimidines
-
Receptors, Glutamate
-
Receptors, Kainic Acid